{
  "id": 20804938,
  "title": "Lipid nanoparticle-delivered Cas13b ribonucleoproteins targeting survivin overcome gemcitabine resistance in pancreatic cancer",
  "url": "https://urgent.news/2026/11/19/lipid-nanoparticle-delivered-cas13b-ribonucleoproteins-targeting",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.18.767627v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, largely due to its poor response to chemotherapy and the development of drug resistance. Survivin (BIRC5), an inhibitor of apoptosis frequently overexpressed in PDAC, contributes to tumor cell survival and gemcitabine resistance, making it an attractive therapeutic target. Here, we developed a lipid nanoparticle…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}